DAPAGLIFLOZIN
Clinical Indication
Type 1 diabetes
Comments
New patients
Date of classification
December 2021
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.